Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

Figure 4

Kaplan-Meier analysis of the complete group of 104 breast cancer patients. (a) Patients with a lower overall immunoreactivity score for MDR1/P-glycoprotein (MDR1/P-gp) expression detected with antibody C219 exhibit significantly longer overall survival. (b) Patients with a lower overall immunoreactivity score for MDR1/P-gp expression detected with antibody JSB-1 exhibit significantly longer overall survival. (c) Cyclooxygenase-2 (COX-2) negative cases exhibit significantly longer overall survival. (d) Patients with a lower overall immunoreactivity score for MDR1/P-gp expression detected with antibody C219 exhibit significantly longer progression-free survival. (e) Patients with a lower overall immunoreactivity score for MDR1/P-gp expression detected with antibody JSB-1 exhibit significantly longer progression-free survival. (f) COX-2 negative cases exhibit significantly longer progression-free survival.

Back to article page